InFocus Clinical Research today announced it has been ranked No. 434 on the 2025 Inc. 5000 list, a significant leap from its position at No. 724 in 2024. The Inc. 5000 recognizes the fastest-growing ...

ARTEMIS Phase 3 trial enrollment exceeding expectations; driven by strong retina specialist and patient enthusiasm for a potential One And Done™ therapy for wet AMD - ARTEMIS enrollment completion ...

We are thrilled to report excellent progress in the ARTEMIS Phase 3 trial, with enrollment driven by robust interest from retina specialists and ...

More information: Melaku N. Getahun et al, FS-Net: Full scale network and adaptive threshold for improving extraction of micro-retinal vessel structures, Pattern Recognition Letters (2025).

Therapy Insight: The Recognition and Treatment of Retinal Manifestations of Systemic Vasculitis Petros Aristodemou; Miles Stanford Disclosures Nat Clin Pract Rheumatol. 2006;2 (8):443-451. 0 ...

News Release 11-Sep-2023 Seeing success and recognition for research on retinal disease and regeneration SUNY Optometry Ph.D. students take top honors with national awards Grant and Award Announcement ...

Optomed Lumo launches a versatile handheld fundus camera, enhancing retinal imaging accessibility in diverse healthcare ...

Q2 2025 Management View President and CEO Nikhil Lalwani described Q2 2025 as a "record-setting quarter for our company with all-time overall company highs in net revenue, adjusted non-GAAP EBITDA and ...

UB faculty member Steven J. Fliesler has been named the 2022 recipient of the Retina Research Foundation’s (RRF) Paul Kayser International Award in Retina Research presented by the International ...